These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2525086)

  • 1. Release of human epidermal growth factor from platelets in accordance with aggregation in vitro.
    Nakamura T; Kasai K; Banba N; Ishikawa M; Shimoda S
    Endocrinol Jpn; 1989 Feb; 36(1):23-8. PubMed ID: 2525086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
    Zahavi M; Rozen P; Zahavi J
    Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG
    Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
    Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
    Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart.
    Purchase M; Dusting GJ; Li DM; Read MA
    Circ Res; 1986 Jan; 58(1):172-6. PubMed ID: 3080260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.